TMPO and gastric cancer: LAP2 protein was widely overexpressed in the cancerous area of tissues compared to non-cancerous areas (Fig. 1A, 47% in stomach cancer, 27% in pancreas cancer, 30% in liver cancer, 40% in bile duct cancer).